A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,712,008 shares of TNGX stock, worth $8.41 Million. This represents 3.75% of its overall portfolio holdings.

Number of Shares
2,712,008
Previous 2,892,663 6.25%
Holding current value
$8.41 Million
Previous $24.8 Million 15.86%
% of portfolio
3.75%
Previous 5.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $11.93 $1.33 Million - $2.16 Million
-180,655 Reduced 6.25%
2,712,008 $20.9 Million
Q4 2023

Feb 13, 2024

BUY
$6.52 - $12.01 $6.33 Million - $11.7 Million
970,873 Added 50.52%
2,892,663 $28.6 Million
Q3 2021

Nov 15, 2021

BUY
$9.56 - $17.3 $18.4 Million - $33.2 Million
1,921,790 New
1,921,790 $24.8 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $273M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.